Mr. David Hochman serves as Managing Partner at Orchestra Medical Ventures. He serves as Board Observer at Vivasure. He also served as Board Member at Maternity Neighborhood and Caliber Therapeutics. He has over 14 years of venture capital and investment banking experience. He is also President of Accelerated Technologies, Inc (ATI), a medical device accelerator managed by Orchestra. Prior to joining Orchestra, Mr. Hochman was Chief Executive Officer of Spencer Trask Edison Partners, LLC, a principal investment partnership focused on early stage healthcare companies. He was also Managing Director of Spencer Trask Ventures, Inc. during which time he was responsible for directing the firm's venture banking group and led financing transactions for over 20 early-stage companies, securing over $420 million in equity capital. Mr. Hochman currently serves as a director of Caliber Therapeutics, Vital Access, BackBeat Medical, and Prescient Medical, an interventional cardiovascular device company Mr. Hochman co-founded in 2004. Mr. Hochman was an advisor and observer to the board of Health Dialog Services Corporation, a world leader in collaborative care management that was acquired in 2008 by the British United Provident Association for $750 million. He was also a co-founder and director of PROLOR Biotech, a biopharmaceutical company developing longer-lasting versions of approved therapeutic proteins, as well as a board advisor to Idera Pharmaceuticals, Inc., a world leader in Toll-Like Receptor-based therapeutics. Mr. Hochman currently serves as a director of the following nonprofit organizations: the Citizens Committee for New York City, the AIDS Action Foundation and the Mollie Parnis Livingston Foundation. He graduated with honors from the University of Michigan. He served as President and Board Member at BackBeat Medical. He also serves as Board Member at Private Practice.